Phospholipase Cb (PLCb) isozymes represent a family of molecules that link G protein-coupled receptors (GPCRs) to an intracellular signaling network. Here, we investigated the function of PLCb isozymes in sensory neurons by using mutant mice deficient for specific PLCb family members. Expression analysis indicated that PLCb3, one of the four isoforms, is predominantly expressed in a subpopulation of C-fiber nociceptors. A subset of these neurons expressed the histamine H1 receptor. Ca 2+ imaging studies revealed that PLCb3 specifically mediates histamineinduced calcium responses through the histamine H1 receptor in cultured sensory neurons. In line with this, we found that PLCb3 2/2 mice showed significant defects in scratching behavior induced by histamine; histamine-trifluoromethyl-toluidine (HTMT), a selective H1 agonist; and compound 48/80, a mast cell activator. These results demonstrate that PLCb3 is required to mediate ''itch'' sensation in response to histamine acting on the histamine H1 receptor in C-fiber nociceptive neurons.
Introduction
Sensory neurons innervating the skin detect a variety of stimuli, including touch, pain, pressure, temperature, and chemicals. They report the presence of these stimuli to the spinal cord, and subsequently to the brain. Nociceptors represent a subpopulation of sensory neurons that are activated by noxious stimuli. They can be broadly divided into two classes: one group has smalldiameter cell bodies and slowly conducting, unmyelinated axons (known as C-fibers), whereas the other has medium-diameter cell bodies and faster conducting, lightly myelinated axons (known as Ad fibers). In addition, C-fiber nociceptors can be subdivided on the basis of histological markers or requirements for neurotropic factors (Molliver et al., 1997; Nagy and Hunt, 1982; Snider and McMahon, 1998) . Although C-fiber nociceptive neurons are mainly involved in pain perception, it has become evident that a specific subset of C-fibers is specialized to report the sensation of ''itch'' (Magerl et al., 1990; Rees and Laidlaw, 1999; Schmelz et al., 1997) . There is also evidence that A-fibers contribute to the itch sensation (Graham et al., 1951; Handwerker et al., 1987; Magerl, 1991) .
Itch is defined as a sensation that evokes scratching behavior. It can be elicited only in the skin, skin-tomucosal transitional surfaces, or certain mucosal surfaces such as the roof of the mouth. Itching is reliably induced by a variety of chemical stimuli, the best example of which is histamine acting on histamine receptors. Histamine or other possible pruritic mediators are mainly released from cutaneous mast cells, which are located close to sensory fibers in the skin (Botchkarev et al., 1997; Hagforsen et al., 2000) . Histamine can excite a subpopulation of polymodal C-fiber nociceptors (Handwerker et al., 1991) . A subset of itch-selective Cfibers has been identified that is insensitive to mechanical and heat stimuli, but responds to histamine with very slow conduction velocities (Schmelz et al., 1997) . However, the precise cellular and molecular mechanisms that transduce the histamine response in sensory fibers are still obscure. Molecular analysis has so far identified four subtypes of histamine receptors, H1-H4 (Bachert, 2002; Haaksma et al., 1990; Oda et al., 2000; Zhu et al., 2001) . Pharmacological experiments have suggested that histamine-induced itching involves the H1, and possibly the H3 or H4, receptors (Bell et al., 2004; Hagermark et al., 1979) . In guinea pig sensory neurons, histamine H1 receptors appear to be expressed in a subset of isolectin B4 + (IB4 + ) neurons (Kashiba et al., 1999) . There is also evidence that histamine H3 receptors are located on peripheral endings of peptidergic nerve fibers in the rat (Ohkubo et al., 1995) .
Numerous G protein-coupled receptors (GPCRs) are expressed in nociceptive sensory neurons. Phospholipase Cb (PLCb) is one of the key players in the signaling cascade that links GPCRs to an intracellular signaling network. Four major G protein-coupled PLCb isoforms have been characterized: PLCb1, PLCb2, PLCb3, and PLCb4. GPCR-mediated hydrolysis of phosphatidylinositol 4,5-biphosphate (PIP 2 ) by PLCb generates two primary intracellular messengers, diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP 3 ), which mediate the activation of protein kinase C (PKC) and intracellular Ca 2+ release, respectively (Exton, 1996) . Moreover, several physiological and functional studies have shown that PLCb signaling is engaged in a diverse range of sensory functions by specifically or selectively coupling to GPCRs. For example, PLCb4 is involved in mediating inflammatory pain in the ventral posterolateral thalamic nucleus (VPL) by coupling to metabotropic glutamate receptor type 1 (mGluR1) (Miyata et al., 2003) . Previously, PLCb3-deficient mice were shown to have enhanced morphine responsiveness (Xie et al., 1999) . PLCb2 signaling is also required to mediate bitter, sweet, and umami taste signal transduction (Zhang et al., 2003) . However, despite indications of an important role for PLC-mediated pathways in sensory signal transduction, there is only indirect evidence supporting their specific functions in primary sensory neurons (Xie et al., 1999) .
In order to understand how this protein family with multiple isoforms plays a role in sensory neurons, (1) we determined the cell type-specific distribution and localization of PLCb isoforms in sensory neurons. (2) We then identified histamine as a PLCb3-dependent agonist by screening agonists using the dorsal root ganglia (DRG) neurons derived from mutant mice and their wildtype littermates. (3) Finally, histamine receptor agonists were intradermally (i.d.) injected into the rostral part of the skin on the back of the mouse, and the itch response was assessed by quantifying subsequent scratching in wild-type and mutant mice. Our data demonstrate that PLCb3 is required to mediate the itch signal generated via histamine H1 receptor activation on peripheral Cfiber nociceptive neurons.
Results

Distribution of Gaq Family Members and PLCb
Isoforms in Adult Mouse DRG and Spinal Cord All phospholipase Cb family members (b1-b4) can be activated by interaction with heterotrimeric G protein a q (Gaq) family members (Gaq, Ga11, Ga14, and Ga15) and are thus functionally linked to a given set of GPCRs. In order to understand how these protein families with multiple isoforms are organized, the expression of Gaq/PLCb mRNAs was comparatively examined in adult mouse DRG and spinal cord by in situ hybridization using digoxygenin-labeled riboprobes. This analysis revealed that three Gaq members (Gaq, Ga11, and Ga14) ( Figures 1A-1D ) and three PLCbs (b1, b3, and b4) (Figures 1I-1L ) are expressed in DRG neurons. In spinal cord, two Gaq members (Gaq and Ga11) and, as previously reported (Miyata et al., 2003) , two PLCb isoforms (b1 and b4), are expressed ( Figures 1E-1H and 1M-1P). Gaq and Ga11 are expressed in every neuron of the DRG and spinal cord as shown . Interestingly, Ga14 is highly expressed in a subset of DRG neurons ( Figure 1C ) and is also expressed in a few motor neurons in the ventral horn of the spinal cord ( Figure 1G ). Ga15 expression was virtually absent in both DRG and spinal cord ( Figures 1D and 1H) . Similarly, three PLCb isoforms, PLCb1, b3, and b4, are expressed at different levels in subpopulations of the DRG neurons ( Figures 1I-1L ). PLCb2 mRNA was not detected (Figure 1J) . Amongst the three PLCbs expressed in DRG neurons, PLCb3 showed the highest expression (Figure 1K) , whereas no PLCb3-positive signals were detected in the spinal cord ( Figure 1O ). PLCb4 mRNA is also expressed in a subset of DRG neurons, but at much lower levels compared with PLCb3 ( Figure 1L ). However, PLCb4 expression was broadly detected in the spinal cord ( Figure 1P ). Faint signals of PLCb1 mRNA were detected in limited regions in both DRG and spinal cord ( Figures 1I and 1M ).
PLCb3 and PLCb4 Are Expressed in Largely Nonoverlapping Subsets of Sensory Neurons
The expression of PLCb1, PLCb3, and PLCb4 in subsets of sensory neurons raises the question of whether these molecules are expressed in distinct or overlapping subsets. We applied double-labeled in situ hybridization with combined probes of PLCb3 and PLCb4 using digoxigenin and fluorescein riboprobes. These double in situ probes were hybridized in parallel on DRG or trigeminal ganglia (TG) sections derived from wild-type, PLCb3 2/2 , or PLCb4 2/2 mice. These experiments indicated that PLCb3 and PLCb4 are primarily expressed in nonoverlapping subsets of both adult DRG (Figures  2A-2C ) and TG neurons ( Figures 2D-2F PLCb3 Expression Is Restricted to C-Fibers, whereas PLCb4 Is Mainly Expressed in A-Fibers Since DRG contains diverse subpopulations of primary sensory neurons, we next determined whether PLCb3 and PLCb4 are expressed in more restricted subsets of these neurons. Nociceptive sensory neurons can be divided into three main populations based on conduction velocity (nonpeptidergic C-fiber, peptidergic Cfiber, and Ad fiber nociceptors). Nonpeptidergic C-fiber nociceptors can be identified by binding of Griffonia simplicifolia isolectin B4 on the cell surface. In the mouse, combined fluorescent labeling for isolectin B4 with in situ hybridization with the PLCb3 probe indicated that 83% (386/465) Figures 3G-3I ), which is known to be exclusively expressed in IB4 + neurons whose peripheral fibers innervate the epidermis in the skin (Zylka et al., 2003 (Zylka et al., , 2005 . Since PLCb3 is expressed in some non-IB4 + neurons, additional doublelabeling experiments with PLCb3 versus Calcitonin Gene-Related Peptide (CGRP) were carried out. We found that 28% (113/401) of PLCb3-expressing neurons coincided with 34% (113/326) of CGRP + neurons (Figures 3J-3L ). DRG neurons can be classified into C-fiber and A-fiber based on the degree of myelination. These two subgroups can be distinguished by NF-200 immunoreactivity, which is considered a marker of myelinated fibers (Lawson and Waddell, 1991) . Double immunolabeling using anti-PLCb3 and anti-NF-200 showed that PLCb3 does not overlap with NF-200 + neurons (less than 2%) ( Figures 3M-3O) . Therefore, these expression data demonstrate that PLCb3 is primarily expressed in IB4 + , MrgD + , and P2X3 + C-fiber nociceptors in the mouse.
In contrast to PLCb3, PLCb4 was not expressed in IB4 + neurons ( Figures 4A-4C ), but rather in a subset of CGRP + neurons ( Figures 4D-4F ). Notably, most PLCb4 was expressed in NF-200 + neurons ( Figures 4G-4I ). Therefore, PLCb4 is primarily expressed in myelinated A-fibers, whereas expression of PLCb3 is restricted to neurons with histological markers indicating unmyelinated, C-fiber nociceptors.
PLCb3 Protein Is Localized Both Peripherally and Centrally
In situ analysis does not provide information as to the localization of the PLCb3 protein. Moreover, it is important to know whether PLCb3 can act peripherally and that PLCb3
+ neurons project to a specific lamina layer known to relay the information to the central nervous system.
To determine the presence of the PLCb3 protein in peripheral nerve fibers, we initially carried out immunostaining of PLCb3 in the mouse skin, sciatic nerve fibers, and DRG culture. However, PLCb3 immunoreactivity was difficult to detect in peripheral nerve fibers, although anti-PLCb3 antibody specifically detected PLCb3 protein in the soma area of the DRG neurons (see Figure S1 in the Supplemental Data). To convince ourselves that PLCb3 is distributed to the peripheral nerve fibers, we examined PLCb3 transport in the rat, which provides a better experimental model for this purpose. Following double ligation of the sciatic nerve for 18 hr, a western blot was performed on nerve segments (w3 mm) cut on various sites, including the proximal and distal sides of the double ligature. The PLCb3 rabbit polyclonal antibody specifically identified PLCb3 protein at the expected molecular weight (w130 kDa) in DRG lysates derived from wild-type mice ( Figure 5A : lane 1), but did not detect PLCb3 protein in the DRG lysates of the PLCb3-deficient mice ( Figure 5A : lane 2). The bands corresponding to PLCb3 were present in each of the rat sciatic nerve segments with much weaker intensity compared with that of the DRG lysates ( Figure 5A : lane 3-6), explaining why PLCb3 immunostaining did work well in DRG soma but wasn't observed in peripheral nerve fibers. The blot was reprobed using an anti b-actin monoclonal antibody to confirm that equal amounts of PLCb3 were present in each lane ( Figure 5A , bottom panel). As shown, PLCb3 significantly accumulated only on the proximal side of the first ligature ( Figure 5A : lane 4) compared with the other nerve segments, including the distal side of the second ligature. This eliminates the possibility that the presence of PLCb3 resulted from sources extrinsic to the nerve cell and demonstrates that PLCb3 present in the adult rat sciatic nerve must be transported anterogradely in peripheral axons from the DRG soma.
To ascertain whether PLCb3 is expressed in central nerve fibers projecting to the spinal cord, immunohistochemical staining was performed in perfused mouse spinal cord sections. Since PLCb3 is not expressed in spinal neurons, as shown in Figure 1O , PLCb3 immunoreactivity in the dorsal horn reflects the projection of the central nerve fiber from DRG neurons ( Figure 5B ). To define the laminar localization of PLCb3, we stained perfused spinal cord sections with Alexa Fluor-conjugated lectin IB4 and PKCg antibody ( Figure 5B ). The former is a marker for lamina II; the latter, for laminae II i and lamina III interneurons. Double immunostaining experiments revealed that PLCb3 immunoreactivity was localized in the superficial region of the dorsal horn that includes the IB4 + laminae, and that it was dorsal to the PKCg + lamina ( Figure 5B ). This result is consistent with the finding that PLCb3 is mainly expressed in IB4 + neurons and expressed in some peptidergic C-fiber DRG neurons. We further sought to determine if PLCb3 is present in the synaptic compartment of the mouse spinal cord. Spinal cord synaptosomes were prepared using the methods described by Guo et al. (2001) . Western blot analysis of PLCb3 clearly shows that PLCb3 colocalizes with the synaptic vesicle marker synaptophysin, a 38 kDa synaptic vesicle protein, indicating that PLCb3 is presynaptically localized at the central terminals of the DRG neurons ( Figure 5C ).
PLCb3 Mediates Histamine-Induced Calcium
Responses by Specifically Coupling to the Histamine H1 Receptor on Sensory Neurons Based on the finding that expression patterns of PLCb3 and PLCb4 are mutually exclusive in sensory neurons, we tested the possibility that they may be specifically coupled to receptors in these different subsets of cells and thus may mediate distinctive sensory signaling. In order to test this hypothesis, we prepared acutely dissociated DRG neurons derived from both adult mice that were deleted for PLCb3 or PLCb4 and from their wildtype littermates and examined the effects of various agonists on [Ca 2+ ] i as a screen for the presence of PLCb3 or PLCb4-specific ligand effects. Adenosine 5 0 -triphosphate (ATP), Uridine 5 0 -triphosphate (UTP), capsaicin, histamine, and bradykinin (BK) have been shown to elicit [Ca 2+ ] i increases in dissociated DRG neurons: ATP is a nonselective agonist that acts on the P2X and P2Y receptors; capsaicin is a specific agonist for TRPV1; BK is a specific agonist for B1R and B2R; histamine is a specific agonist for histamine receptors; and UTP is a selective agonist for P2Y2/P2Y4 receptors (Caterina et (Table 1) or the mean of peak amplitude (mean F340/F380 ratio) when treated with these two ligands ( Figure 6A ). In wild-type cells, on average, 15% to w20% of the cells in the population responded to BK (1 mM), histamine (100 mM), or UTP (100 mM). These three agonists are thought to induce increases in [Ca 2+ ] i through PLC activation. Nevertheless, the percentage of neurons responding to BK or UTP was not different between cells derived from wild-type or mutant mice (Table 1) , and no significant differences in the mean F340/F380 ratio were observed between wildtype and mutant cells upon application of BK or UTP (Kruskal-Wallis ANOVA analysis: p > 0.1) ( Figure 6A ). In contrast, when histamine was applied, the percentage Shown are 1 mm confocal microscope optical sections of adult DRG or trigeminal ganglia (TG) derived from wild-type and PLCb3 or PLCb4 knockout mice and processed in parallel for double-label in situ hybridization with combined probes for PLCb3 and PLCb4. PLCb4-positive cells were counted as cells having a fluorescence level greater than the background fluorescence resulting from identically processed sections derived from PLCb4 2/2 mice. By alternating the light source or adjusting the contrast of confocal microscopy, we observed that the PLCb4-positive signals were restricted to the cell soma. In all panels, PLCb3 is in red, and PLCb4 in green. (A-F) Double-label in situ with PLCb3 and PLCb4 probes in DRG and TG sections. PLCb3 staining mostly does not overlap with PLCb4 staining. (G-I) Double-label in situ on trigeminal sections derived from PLCb3-deficient mice. (J-L) Double-label in situ on DRG sections derived from PLCb4-deficient mice. These controls illustrate the signal specificity of each probe. Scale, bottom right, is the same for all panels (80 mm) unless indicated otherwise. of responding neurons showing calcium responses was significantly decreased only in PLCb3-deficient cells (Table 1 ). The mean F340/F380 ratio induced by histamine appeared to be at basal level (1.01 6 0.01, n = 40) in PLCb3 2/2 cells compared with wild-type (1.43 6 0.05, n = 23) and PLCb4 2/2 cells (1.60 6 0.13, n = 15). To further characterize the histamine-sensitive neurons, we examined the responses to 100 mM histamine followed by a mixture of 1 mM BK and 100 mM UTP. All histamine-sensitive neurons in wild-type and in PLCb4 2/2 cells also responded to a mixture of BK and UTP (Figure 6B) . A mixture of BK and UTP elicited increases in [Ca 2+ ] i in w30% of wild-type and mutant cells, which is comparable to the combined percentage of neurons responding when BK or UTP were applied individually. These results indicate that histamine-sensitive neurons consist of two different subsets: BK-sensitive or UTPsensitive cells.
Next, we examined the activation and desensitization kinetics in response to histamine. Application of 100 mM histamine to wild-type neurons elicited a rapid rise in [Ca 2+ ] i , with peak responses achieved within 10-20 s. The successive application of histamine led to a reduced response compared with the peak height elicited by the first application ( Figure 6C ), indicating desensitization.
Since histamine-induced calcium responses may result from the activation of four isotypes, H1, H2, H3, and H4, we tried to determine which receptor mediates the histamine-induced increase in [Ca 2+ ] i . We used histamine receptor antagonists relatively specific for each receptor isotype: mepyramine (H1 receptor antagonist), The sciatic nerves of a three-week-old rat were ligated in two places for 18 hr, after which the ligatures were removed and 3 mm segments homogenized. The tissue extracts were then subjected to a 4%-12% gradient SDS-PAGE, the protein was transferred onto nitrocellulose, and a western blot was performed using anti-PLCb3 antibody (1:800). After that, the blot was reprobed by b-actin antibody (1:20,000), which was used as a control to compare levels of protein loading in each lane. To show PLCb3 antibody specificity, the same amounts of DRG lysate derived from wild-type and PLCb3-deficient mice were loaded in lane 1 and 2, respectively, and subjected to immunoblot analysis. Each lane corresponds to the DRG segments illustrated. cimetidine (H2 receptor antagonist), and thioperamide (H3 receptor antagonist). As previously reported (Nicolson et al., 2002) , only the H1 receptor antagonist, mepyramine (10 mM), abolished the histamine-induced calcium responses in wild-type neurons. BK and UTP responsiveness, however, were not changed in the presence of mepyramine ( Figure 6D) .
Single in situ analysis revealed that the H1 receptor is expressed in 14.5% (58/399) of the sensory neurons, and all of the H1-positive cells were observed to be amongst the small-diameter neurons ( Figure 6E ). Moreover, double in situ analysis confirmed that 90% (26/29) of the H1 receptor-expressing neurons coexpressed with PLCb3 ( Figure 6F ). Western blotting detected the H1 receptor in mouse whole DRG, and the level of expression of histamine H1 receptor was not changed in mutant mice ( Figure S2B ), indicating that absence of PLCb3 or PLCb4 did not effect the expression levels of the H1 receptor in the DRG.
In order to identify the types of neurons that show histamine responses, acutely dissociated mouse DRG neurons were labeled with IB4 before recording. 2 neurons, 4.1% (4/97) showed calcium responses. Taken together, these results demonstrate that PLCb3 is specifically coupled to the histamine H1 receptor and mediates histamineinduced calcium responses in a sensory neuron population that consists almost entirely of IB4 + neurons.
PLCb3 Is Required for Scratching Induced by Histamine Receptor Agonists
The identification of histamine as a PLCb3-specific agonist led to speculation that PLCb3 might mediate itching in vivo. Pruritic compounds, including histamine, were injected i.d. into the rostral part of the back skin of wild-type, PLCb3-, or PLCb4-deficient mice, and itch was assessed by quantifying the scratching. Mice used in the scratching behavioral assay were littermates or age-matched, but not sex matched because in preliminary experiments we couldn't find any significant sex differences in scratching reactions to the tested drugs ( Figure S3 ). In the case of PLCb4 2/2 mice, we were not able to determine the scratching responses since these mice suffer from locomotor ataxia of their hindlimbs, as previously reported . Figures 7A-7D show the time course of scratching bouts for 30 min at 5 min intervals after the injection of each compound. Typically, the first scratching was observed within 2 to w3 min following injection, and peaked within 10 min in wild-type mice. Comparison of wild-type and PLCb3 2/2 mice revealed significant differences in scratching initiation time (T i ), peak, and total bouts of scratching against compounds tested (Figure 7 ). When histamine was applied, PLCb3 2/2 mice showed delays in the first scratching response (WT: T i = 143 6 10 s, versus KO: T i = 227 6 19 s; p = 0.002), with a significant reduction in mean total bouts of scratching over a period of 30 min (WT: 152 6 17, versus KO: 46 6 9; p = 0.001), but with the same peak at 5 to w10 min as in wild-type mice. When the selective histamine H1 receptor agonist HTMT was applied, the effect of PLCb3 deficiency was the most pronounced. The total mean incidence of scratching in wild-type mice was 117 6 22, whereas in PLCb3-deficient mice it was only 7 6 4 bouts (Mann-Whitney Test; p < 0.001), which is almost comparable to the response elicited by saline injection ( Figure 7E ). The total mean number of scratching bouts elicited by saline over the 30 min was 5 6 2 bouts (mean 6 SEM., n = 6). In wild-type mice, injection of clobenpropit, an H3 antagonist and H4 agonist, evoked the highest total incidence of scratching (362 6 47) and also showed the fastest response (T i = 83 6 8 s) among the compounds tested. The most significant difference was observed in scratching at peak time and first scratching response (KO: T i = 272 6 65 s; p = 0.016), while the incidences of scratching after 10 min were not significantly different between wild-type and PLCb3 2/2 mice ( Figure 7C ). Among the tested drugs, the response to clobenpropit shown in PLCb3 2/2 mice was the least affected ( Figure 7E ). Compared with wild-type mice, only a 45% decrease in the total number of scratching bouts (WT: 362 6 47, versus KO: 196 6 52; p = 0.033) was observed, suggesting that a PLCb3-independent mechanism exists in clobenpropit-induced scratching responses.
Itch in humans and rodents can be triggered by histamine release from skin mast cells upon mast cell degranulation. Among mast cell degranulators, compound 48/80 has been reported as a potent mast cell histamine releaser in both in vitro and in vivo studies (Kuraishi et al., 1995; Nakayama et al., 2002) . Thus, we next examined the potential role of PLCb3 in compound 48/80-induced scratching responses. When compound 48/80 was injected, significant scratching was observed in wildtype mice, which peaked within 10 min and extended for 30 min, whereas in PLCb3 2/2 mice, the peak was significantly delayed with significant reduction at all Ratio (F340/F380) baselines of all individual neurons measured for 40 s prior to agonist application. Responses were defined by the peak value in the change of the ratio that was greater than 20% of the baseline value for each neuron, when each drug was applied; the sample size represents the fraction of responding neurons per total number of cells tested.
NeuronFigure 6. Functional and Expression Evidences for Coupling Specificity of PLCb3 with Histamine H1 Receptor in Adult Mouse DRG Neurons
(A) Agonist-induced calcium responses in dissociated DRG neurons derived from adult wild-type, PLCb3 2/2 , and PLCb4 2/2 mice. Treatments with 1 mM bradykinin (BK), 10 mM capsaicin (Cap), 100 mM histamine (HTM), ATP, and UTP were performed. The mean F340/F380 ratio was used as a measure of peak amplitudes for the indicated agonist-induced increase of [Ca 2+ ] i . The magnitudes of histamine-evoked calcium responses were significantly decreased in PLCb3 2/2 cells compared with wild-type and PLCb4 2/2 cells (Kruskal-Wallis; for histamine, *p < 0.001, n = 40), but for other agonists, there was no significant difference in increases of mean F340/F380 ratios between any two of these three genotypes (Kruskal-Wallis; for ATP, p = 0.57, n = 23; for BK, p = 0.15, n = 20; for capsaicin, p = 0.38, n = 40; and for UTP, p = 0.10, n = 12). Each point is the mean 6 SEM of at least three independent experiments. (B) In wild-type or PLCb4 2/2 cells, all neurons responding to histamine also responded to a second challenge with a mixture of 1 mM BK and 100 mM UTP. In PLCb3-deficient cells, the 100 mM histamine-evoked increase in [Ca 2+ ] i is significantly impaired without affecting the responses to BK plus UTP. times ( Figure 7D ). The mean of total bouts of scratching was decreased by 77% compared with wild-type mice (WT: 198 6 33, versus KO: 47 6 13; p = 0.002) as shown in Figure 7E . These results suggest that PLCb3 mediates the itch sensation that results from mast cell activation in vivo.
Discussion
PLCb isozymes represent one of the key families of signaling molecules that link GPCRs to intracellular networks. Although a large family of GPCRs is expressed in primary sensory neurons, it is not clear what roles the isozymes of a given PLC family play in sensory neurons in vivo, i.e., to what extent they determine the specificity of individual signaling pathways. This study demonstrated a high degree of cellular and functional specificity for different PLC isoforms. We found that PLCb3 is predominantly expressed in C-fiber nociceptive peripheral nerves, that it is specifically coupled to the histamine H1 receptor, and that it mediates histamine-induced scratching (itch).
Functional Implications and Distribution of PLCb Isozymes in Adult Mouse DRG Neurons
PLCb activity is regulated by a number of GPCRs linked to the Gaq subfamily (Gaq, Ga11, Ga14, and Ga15) of heterotrimeric GTP binding proteins (G proteins). In addition, two of the PLCb isoforms (PLCb2 and PLCb3) can be activated by the Gbg subunit dissociated from Gai/o subfamily in a pertussis toxin-sensitive manner (Smrcka et al., 1991) . PLCb isoforms differ in their sensitivity to stimulation by Gaq subunits or Gbg. These biochemical properties may underscore potential PLCb isoform-specific differences in signaling.
In adult mouse DRG, PLCb3 is a major isoform with lower levels of PLCb4 and much lower levels of PLCb1. This is analogous to the expression pattern of PLCb isoforms observed in Purkinje cells in the cerebellum ), but it is essentially different from expression patterns in other brain regions, in which PLCb1 and PLCb4 represent the major neuronal PLCb isoforms. In contrast to PLCb1 and PLCb4, PLCb3 is not expressed in central nervous tissues (e.g., spinal cord, thalamus, cortex, etc.) implicated in somatosensory Mice were given an intradermal injection of saline (n = 6 for wild-type), histamine (10 mmol; n = 8 for wild-type; n = 5 for PLCb3
), HTMT (0.1 mmol; n = 7 for wild-type; n = 14 for PLCb3 2/2 ), clobenpropit (0.1 mmol; n = 8 for wild-type; n = 7 for PLCb3 2/2 ), and compound 48/80 (30 mg; n = 8 for wild-type; n = 7 for PLCb3 2/2 ). Scratch bouts directed to injection site were recorded during the first 30 min after injection. (A-D) Time course of scratching after an intradermal injection of each drug for wild-type (filled rectangle) versus PLCb3 2/2 (filled circles). The number of bouts of scratching is indicated at each 5 min interval during a 30 min test period. Each value represents the mean 6 SEM. Asterisks indicate the time point at which wild-type mice were significantly different from PLCb3 2/2 mice (*p < 0.05; two-way ANOVA with Bonferroni correction). (E) The total number of bouts of scratching for wildtype and mutant mice was determined after following the mice for 30 min. As a control, the mice were given an intradermal injection of the same volume of saline. Each value represents the mean 6 SEM of the total count. Compared to wild-type mice, PLCb3 2/2 mice show significant differences in scratching behavior to the tested drugs (two-way ANOVA: p = 0.001 for histamine, p < 0.001 for HTMT; Mann-Whitney test, p = 0.002 for compound 48/80, p = 0.033 for clobenpropit).
Neuroncircuits Rubio et al., 1999; Watanabe et al., 1998) .
Our data revealed that PLCb3 is highly expressed in a subpopulation of the C-fiber nociceptors that includes 85% of the IB4 + neurons and 34% of the peptidergic neurons, whereas PLCb4 is mainly expressed in A-fibers. Differential expression strongly suggested that PLCb3 and PLCb4 could play different roles in signaling. In support of this argument, PLCb3 + and PLCb4 + neurons in the DRG contain an array of different molecular components. Some of these differentially expressed components include the MrgD receptor, Ga14, and TRPC3 (data not shown). Currently, we are investigating whether these molecules are directly coupled to PLCb3 and what roles they may play in sensory function.
C-fiber nociceptors send their central projections to the superficial regions of the dorsal horn in the spinal cord. Peptidergic populations target lamina I of the superficial dorsal horn, while the IB4 + population is focused on lamina II (Hunt and Mantyh, 2001 ). These layers contain projection neurons that transmit various kinds of sensory information, such as pain or itch, to related brain regions, including the midbrain, thalamus, and limbic regions (Braz et al., 2005; Wallengren, 2005) . As revealed by double immunostaining, PLCb3 is localized to lamina I and II dorsal to the PKCg + layer in the dorsal horn. Furthermore, we showed that PLCb3 is colocalized with synaptophysin at the synaptic vesicle in central terminals, but not in the spinal neurons. Therefore, our results indicate that PLCb3 is located in both peripheral nerve fibers and central presynaptic regions and could play a number of roles in signal transduction and transmission.
The Signaling Specificity of PLCb Isoforms in the DRG Neurons Receptor-mediated, PLC isoform-specific or -selective signaling is often found in vivo. Several genetic studies have shown that PLCb1 is involved in signaling in the cerebral cortex and hippocampus by coupling predominantly to the muscarinic acetylcholine receptor (Kim et al., 1997) , whereas PLCb4 works through the metabotropic glutamate receptor in the cerebellum or thalamus Miyata et al., 2001 Miyata et al., , 2003 , illustrating that a specific combination of G proteins active in signaling from a given receptor can be involved in the selective activation of PLCb isozymes. Such specificities can be generated in several different ways. For example, a conserved PDZ binding motif at the C terminus of a PLCb isoform can interact with a given scaffolding protein and form a physically and functionally distinct signaling unit (reviewed in Ranganathan and Ross, 1997) . In addition, the signaling specificity of PLCb isoforms can be achieved through their unique distribution or differential level of expression in a given tissue or cell Kim et al., 1997; Miyata et al., 2003) .
Our data also suggest the possibility of PLC isoformreceptor-specific signaling. As previously reported (Nicolson et al., 2002) , we found that the application of histamine evoked a calcium response in a fraction (w16%) of DRG neurons in culture by direct activation of the H1 histamine receptor. Most histamine-sensitive cells appear to be IB4 + neurons in which the PLCb3 isoform is predominantly expressed. Importantly, we found that histamine-induced calcium responses were significantly impaired in PLCb3-deficient, but not PLCb4-deficient, DRG neurons in culture. Moreover, histaminesensitive cells appear to respond to either BK or UTP. In the majority of tissues, BK and UTP have been reported to induce PLC activation through the Gaq/Ga11 G protein isoform. In the DRG, the BK receptors, the B1R and B2R receptors, have been identified in nociceptive neurons (Ma et al., 2000; Seabrook et al., 1997) , and UTP can excite cutaneous C-fiber nociceptors through the G proteinmediated receptor P2Y2 (Molliver et al., 2002; Stucky et al., 2004) . However, in neither PLCb3-nor PLCb4-deficient cultured DRG neurons was the calcium responsiveness elicited by BK or UTP affected. Only histamine responses required the presence of PLCb3, suggesting that PLCb3 specifically couples to the histamine H1 receptor in cultured DRG neurons. These results raise the question of how signaling specificity is achieved in response to different agonists in the same cell. It is likely that there are multiple intracellular pathways to induce agonist-specific increases in [Ca 2+ ] i . However, the nature of these pathways still remains unclear. One possibility is that PLCb1 may be responsible for calcium responses elicited by BK or UTP since PLCb1 mRNA is weakly detected in small-diameter neurons. In addition, we cannot rule out the possibility that other novel PLC isoforms such as PLC3 or PLCh may play a role. These two PLC isoforms were also reported to be, in part, coupled to GPCRs through the release of Gbg (Wing et al., 2003; Zhou et al., 2005) . In either event we are driven to postulate the formation of isoform-specific circuitry in specifically differentiated sensory neurons.
Neural Mechanisms of Itch
With regard to the peripheral mechanisms of the itch sensation, two distinct models have been proposed (McMahon and Koltzenburg, 1992) . The specificity theory proposes that a set of primary afferents exclusively responds to pruritic stimuli. In contrast, the selectivity hypothesis assumes that some afferents respond to both pruritic and painful stimuli, whereas others respond only to painful stimuli, and that the two classes have different central connectivity. Our calcium mobilization assays revealed that at least four distinct subpopulations of chemoreceptor combinations could exist in DRG neurons in culture: BK + /Histamine 2 , BK + /Histamine + , UTP + /Histamine 2 and UTP + /Histamine + . Since BK is mainly algogenic and not pruritogenic, the selectivity model is the more likely explanation for the sensation of itch. Unlike the case with BK, it is not clear yet whether UTP can act as an algogenic agent or pruritic agent in the periphery. Thus, it is possible that two different subsets of histamine-sensitive neurons may have distinct functions in detecting the itch sensation. In support of this, BK-induced firing patterns (Kasai et al., 1998) appear to be different from the pattern evoked by UTP, which showed a delayed (>1 min) and prolonged burst of action potentials (>2 min), respectively, in nociceptive neurons (Molliver et al., 2002; Schmelz et al., 2003) . Such electrophysiological properties coincide with the observation that the itch sensation starts with a delay of 30 to w60 s following histamine application by iontophoresis, reaching a maximum at 2 to w3 min (Schmelz, 2001 ). This suggests that the UTP + /histamine + neuron subset might be more relevant for sensing histamine-evoked pure itch, while BK + /histamine + neurons may be responsible for grading or regulating the intensity of the itch sensation.
PLCb3 Is a Major Mediator for Sensation of Histamine-Induced Itch In Vivo Since PLCb3 is highly expressed in C-fiber nociceptive sensory neurons, we initially reasoned that PLCb3 might have a role in nociception. However, mice lacking PLCb3 showed normal behavior in various pain behavior tests, such as the hot-plate test run at different noxious temperatures, Von-Frey, formalin, and tail immersion tests (data not shown), precluding a specific role for PLCb3 in transducing acute or inflammatory pain. In addition, we also observed no difference in thermal preference behavior at the innocuous temperatures (data not shown).
In the skin, histamine is known to be a major mediator that is released into dermis following mast cell degranulation. This event appears to be a primary trigger for the itch sensation, which is mediated by C-fiber nociceptors located in the uppermost skin layer (Fjallbrant and Iggo, 1961; Schmelz et al., 1997; Tuckett and Wei, 1987) . However, the signaling mechanisms underlying histamineinduced itch in the periphery are unclear. The present study showed significantly impaired scratching reactions in PLCb3 2/2 mice in response to i.d. injection of histamine. This data appear to be very similar to a scratching defect observed in PLCb3 2/2 mice when compound 48/80 was injected, which is consistent with the fact that histamine is a major mediator released from mast cells. Based on our finding that histamineinduced calcium responses were mostly eliminated in PLCb3-deficient DRG neurons in culture, it is likely that the scratching response to exogenous histamine results from direct action on sensory neurons expressing both histamine receptors and PLCb3. Furthermore, PLCb3-deficient mice showed almost complete defects in scratching responses evoked by HTMT, a selective H1 receptor agonist, which agrees with the finding that histamine-induced calcium responses in DRG neurons were completely eliminated by pretreatment with mepyramine, an H1 antagonist. In addition, previous behavioral studies have shown that the H1 receptor antagonist mepyramine significantly reduced scratching when applied following the application of histamine or compound 48/80 (Bell et al., 2004; Hagermark et al., 1979; Sugimoto et al., 1998) . Therefore, we conclude that PLCb3 mediates the itch sensation evoked by histamine released from mast cells via the histamine H1 receptor on a subset of peripheral C-fiber nociceptors, which are mainly IB4 + neurons.
On the other hand, one study reported that compound 48/80 can induce scratching behavior in mast celldeficient mice (Inagaki et al., 2002) . However, it is not clear if a mast cell-independent pathway contributes to scratching behavior under the normal physiological condition.
Since both the H1 receptor and PLCb3 are known to be broadly expressed in peripheral tissues or cells, the phenotype in PLCb3 2/2 mice might conceivably result from cells other than the primary sensory neuron. One possibility, for example, is that the H1 receptor in keratinocytes could be involved in mediating itch responses via effects on cytokine production. However, this seems highly improbable since the time course of histamine-induced cytokine production in keratinocytes has been shown to occur in the order of an hour (Matsubara et al., 2005) , while the scratching response is rapid and occurs on a time scale of minutes. Moreover, PLCb3 is not likely to be implicated in the neural circuit that extends beyond the sensory cells since PLCb3 is not expressed in the spinal neurons or in higher brain areas responsible for somatosensation. Indeed, the scratching events appeared to be localized to the site of test agent application. Additionally, when compounds tested were injected intraperitoneally, the resultant behaviors such as grooming, mouse activity (bearing and locomotion), or some minor scratching were observed to be the same in wild-type and PLCb3 2/2 mice. These arguments further support the idea that C-fiber nociceptors coexpressing both PLCb3 and the H1 receptor are primarily responsible for mediating the itch sensation at the level of the skin.
Beside histamine H1 receptors, H3 or H4 receptors may be involved in scratching responses since a pharmacological study showed that the scratching response in BalbC mice was induced by application of clobenpropit, which is both an H4 receptor agonist and an H3 receptor antagonist (Bell et al., 2004) . Our study showed that clobenpropit evoked an unusually high scratching response in C57BL/6. The mean total number of bouts of scratching was three times higher than scratching induced by HTMT. This may reflect differences in mouse strains, which can markedly influence scratching responses to drugs (Inagaki et al., 2001) . Although clobenpropit-induced scratching showed a reduction in PLCb3 2/2 mice, significant scratching responses still remained. This suggests that in clobenpropit-mediated scratching there are at least two distinct mechanisms that mediate the scratching behavior, and that they act via PLCb3-dependent and -independent pathways. However, further studies are required to determine the molecular and cellular mechanisms underlying clobenpropit-dependent scratching in vivo.
Taken together, the available data are consistent with the notion that the H1 receptor-PLCb3-mediated pathway is a major component of the in vivo itch response to histamine. This work clearly defines the signaling events that generate the stereotypic ''itch-scratch'' behavior.
Experimental Procedures Animals
PLCb3 (Xie et al., 1999) and PLCb4 knockout mice were backcrossed seven and five generations, respectively, onto a C57BL/6 background. Animals were obtained by mating heterozygous animals. Three-week-old wistar rats were used in sciatic nerve ligation experiments. All experiments were conducted according to protocols approved by The California Institute of Technology Animal Care and Use Committee.
Preparation and Culture of Mouse DRG Neuron
The dorsal root ganglia were isolated from adult mice (1 to w2 month old) and cultures were prepared based on the method described previously (Chopra et al., 2000) . For details, see Supplemental Experimental Procedures.
In Situ Hybridization and Immunofluorescence Nonisotopic in situ hybridization on frozen 14 mm thick sections was performed as previously described using cRNA probes (Ma et al., 1996; Perez et al., 1999) . For immunofluorescence, DRGs were collected from perfused mice and processed. Four to eight confocal images (w1 mm optical thickness) from adult wild-type mice were counted to determine the percentage of PLCb3-positive DRG neurons that coexpressed a given marker. We also checked by counting the percentage of cells expressing a given marker that coexpressed PLCb3. Details are available (see Supplemental Experimental Procedures).
Ca
2+ Imaging Measurement of [Ca 2+ ] i at the individual cell level was performed as previously described (Dong et al., 2001; Han et al., 2002) . Changes in the intracellular Ca 2+ levels in acutely dissociated neurons derived from wild-type or mutant adult mouse DRG were monitored using the Ca 2+ -sensitive dye fura-2. For details of calcium imaging, see Supplemental Experimental Procedures.
Synaptosome Preparation
Subcellular fractionation and isolation of synaptosomes from C57BL/6 mice spinal cords were performed using a method described previously (Keller et al., 1997) . Details are available (see Supplemental Experimental Procedures).
Sciatic Nerve Ligations
Wistar rats (3 weeks old) were anaesthetized by an intraperitoneal injection of ketamine (44 mg/kg) and xylazine (8 mg/kg). The sciatic nerves were exposed and a double ligation was made by tying sutures around the nerve. After 18 hr the rats were killed by inhalation of a rising level of CO 2 . The nerves were dissected out, the thread was removed, and 3 mm segments were cut on the four different sites proximal and distal to the ligature and homogenized in cold TX/G buffer (TBS with 1% TX-100, 10% glycerol, and a protease inhibitor cocktail tablet) with a probe sonicator for 10 s. Homogenates were spun at 14,000 rpm for 20 min at 4 C, and the supernatant was subjected to SDS-PAGE and immunoblot analysis.
Scratching Behavior
Littermates or age-matched male or female mice of 2 to w4 months of age, weighing 20-28 g, were used in the experiments. Each mouse was used for only one experiment. All animals were habituated to the observation chamber for >2 hr before injections. As previously described (Bell et al., 2004) , the itch-inducing properties of histamine, HTMT, clobenpropit, and compound 48/80 were studied by administering the drugs i.d. into the rostral part of the back skin via a 23 G needle in a volume of 100 ml. Injection of saline solution was used as a control. The dose of agonist was selected on the basis of its ability to elicit scratching in each mouse studied, and with the aim of eliciting more than 50% of maximum scratching response. A bout of scratching was defined as multiple scratch movements with hind paws to the area around the injection site. The degree of scratching was quantified as the total number of bouts as well as the cumulative number of bouts (summed at 5 min intervals) over the 30 min observation period. Experiments were carried out blind as to the genotype of the animals or the nature of the drug.
Statistical Analysis
The data were expressed as the mean values with standard error. Kruskal-Wallis ANOVA was employed to compare [Ca 2+ ] i increase as a response to tested agonists between any two of three groups (wild-type, PLCb3 2/2 , and PLCb4 2/2 DRG neurons). In the case of scratching behavior, statistical comparisons were performed using Student's t test, Mann-Whitney's U test at an unequal variance, or Kruskal-Wallis ANOVA. Two-way ANOVA with Bonferroni correction was employed to reveal a significant effect of genotype on time course scratching behavior, as indicated. When the p value was smaller than 0.05, the difference was considered to be significant.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/52/4/691/DC1/.
